News|Articles|January 24, 2025

AJMC® in the Press, January 24, 2025

Higher out-of-pocket costs are linked to lower adherence to cardiac rehabilitation among US adults, impacting patient outcomes.
Blood-based colorectal cancer tests may lead to higher costs and worse outcomes compared to fecal immunochemical tests.
Fecal immunochemical tests are more effective and cost-efficient for colorectal cancer screening, highlighting the need for strategic test prioritization.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from News Medical & Life Sciences referenced a study published in the December 2024 issue of The American Journal of Managed Care^® (AJMC^®). The study, “Out-of-Pocket Spending for Cardiac Rehabilitation and Adherence Among US Adults,” found that those who had higher out-of-pocket spending had lower adherence to cardiac rehabilitation.

An article from Becker’s GI & Endoscopy highlighted an article published on AJMC.com, the website of AJMC. The article highlighted, “Prioritizing Blood-Based Colorectal Cancer Tests May Lead to Higher Costs, Worse Outcomes,” reported on a study that found that fecal immunochemical tests were more effective in screening for colorectal cancer in both outcomes and in cost.